<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR82">
 <label>82.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Michot</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Albiges</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Chaput</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Saada</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Pommeret</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Griscelli</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Balleyguier</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Besse</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Marabelle</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Netzer</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Merad</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Robert</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Barlesi</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Gachot</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Stoclin</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report</article-title>
  <source>Ann Oncol</source>
  <year>2020</year>
  <volume>31</volume>
  <fpage>961</fpage>
  <lpage>964</lpage>
  <?supplied-pmid 32247642?>
  <pub-id pub-id-type="pmid">32247642</pub-id>
 </element-citation>
</ref>
